Regulatorisk
Press releases
Press releases
Year
Icke-regulatorisk
Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation
Regulatorisk
Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine
Icke-regulatorisk
Integrum establishes Center of Excellence in Ukraine
Icke-regulatorisk
Integrum’s MDR certification is completed for the OPRA[TM] Implant System
Regulatorisk
Record sales and profitability
Regulatorisk
Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)
Icke-regulatorisk
Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation
Icke-regulatorisk
Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data
Regulatorisk
Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023
Icke-regulatorisk
Clinical study of Integrum’s OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense
Regulatorisk
Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023
Loading...